LD-2 disclosure · 4th Quarter - Report
JAZZ PHARMACEUTICALS
Client
- Description
- ​Biopharmaceutical company.
- Location
- California · United States of America
Registrant
- Description
- Government Relations.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxicating hemp.
LobbyistsJOHN MICHAEL GONZALEZ · TIMOTHY A MOLINO · MATTHEW LEFFINGWELL
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services.
LobbyistsJOHN MICHAEL GONZALEZ · TIMOTHY A MOLINO · MATTHEW LEFFINGWELL
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
Issues related to FDA enforcement of non-FDA approved, cannabis derived CBD products in H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; Issues related to the Ag/FDA amendment - technical correction to hemp in H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; Issues related to intoxicating hemp products.
LobbyistsTIMOTHY A MOLINO · MATTHEW LEFFINGWELL